Nephros Inc
NEPH- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001196298
No open-market purchases or sales by Nephros Inc insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.0M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Nephros Inc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- 0 vs. Q2 2021
- Shares held
- 1.70M
- +41.5K (+2.5%) vs. Q2 2021
- Total value
- $14.9M
- −$1.99M (−11.7%) vs. Q2 2021
- New holders
- 2
- 6 more added
- Sold out
- 2
- 4 more reduced
2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NEPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 33 | $19.0M |
| Q1 2026 | 27 | $16.0M |
| Q4 2025 | 35 | $25.9M |
| Q3 2025 | 24 | $23.7M |
| Q2 2025 | 21 | $19.8M |
| Q1 2025 | 18 | $8.02M |
| Q4 2024 | 18 | $6.91M |
| Q3 2024 | 17 | $7.33M |
| Q2 2024 | 19 | $9.18M |
| Q1 2024 | 18 | $9.40M |
| Q4 2023 | 18 | $15.0M |
| Q3 2023 | 14 | $6.35M |
| Q2 2023 | 16 | $6.63M |
| Q1 2023 | 18 | $4.57M |
| Q4 2022 | 19 | $4.94M |
| Q3 2022 | 18 | $3.95M |
| Q2 2022 | 17 | $968.0K |
| Q1 2022 | 16 | $2.83M |
| Q4 2021 | 17 | $9.15M |
| Q3 2021 | 17 | $14.9M |
| Q2 2021 | 19 | $60.1M |
| Q1 2021 | 21 | $34.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Nephros Inc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cowen Prime Advisors LLC | 660,150 | $5.79M | 2.15% | +33,700+5.4% | Added |
| Samjo Capital LLC | 550,000 | $4.82M | 3.54% | +900+0.2% | Added |
| Bard Associates Inc | 234,208 | $2.05M | 0.69% | +2,700+1.2% | Added |
| Vanguard Group Inc | 101,618 | $891.0K | 0.00% | +1,682+1.7% | Added |
| HighTower Advisors, LLC | 55,710 | $488.0K | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 36,249 | $318.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 18,079 | $158.0K | 0.00% | −5,395−23.0% | Reduced |
| Morgan Stanley | 13,837 | $121.0K | 0.00% | +9,004+186.3% | Added |
| Millennium Management LLC | 13,424 | $118.0K | 0.00% | −1,599−10.6% | Reduced |
| Elkhorn Partners Limited Partnership | 8,500 | $75.0K | 0.05% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4,574 | $40.0K | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 3,500 | $31.0K | 0.00% | 00.0% | Unchanged |
| Total Clarity Wealth Management, Inc. | 653 | $6.00K | 0.00% | +653 | New |
| Bank of America Corp | 169 | $1.00K | 0.00% | +109+181.7% | Added |
| FMR LLC | 91 | $1.00K | 0.00% | +91 | New |
| Wells Fargo & Company | 51 | $0 | 0.00% | −5−8.9% | Reduced |
| UBS Group AG | 11 | $0 | 0.00% | −16−59.3% | Reduced |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −350−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Wexford Capital LP | – | – | – | – | Not filed |
| Cowen Prime Services LLC | – | – | – | – | Not filed |